Study guide

11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

Key Takeaways Explain This Topic AI

A Utah manufacturer or wholesaler may furnish prescription drugs only to a person licensed to possess, dispense, or administer them, delivered to the licensed premises or an authorized agent (R156-17b-615(12)–(13)).

A Utah pharmacy may buy drugs sold outside the normal course of business, such as at bankruptcy or auction, only with a seller pharmacist's certificate and its own pharmacist's determination that the drugs are safe (Utah Code § 58-17b-615).

A Utah pharmacy may sell repackaged or compounded drugs to a practitioner labeled "for office use only," for administration in the office and not for dispensing, and compounded controlled substances are excluded (Utah Code § 58-17b-624).

A Utah pharmacy may deliver a prescription only in person at the pharmacy, or by USPS, licensed common carrier, or supportive personnel with reasonable precautions to ensure delivery or return (Utah Code § 58-17b-602(9)).

Utah delivery rules require temperature-appropriate, tamper-evident packaging, written policies for lost or compromised shipments, and a way to offer counseling (R156-17b-608(1)).

Last updated: September 2026

11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

Blueprint items 4.1 (ordering, acquisition, and distribution) and 4.3 (delivery of drugs) are covered here. Schedule II ordering (Form 222 and CSOS) is in Section 11.1, and the DEA 5% distribution rule is in Section 8.2.

Where a pharmacy may buy drugs

Licensed sources only. Under R156-17b-615, a manufacturer or wholesaler may furnish prescription drugs only to a person licensed by DOPL (or another state) to possess, dispense, or administer them . It must deliver only to the licensee's business address on the license , or to an authorized agent whose identity and authority are established.

Controlled substances may be distributed only by a licensee, and only on an order form under DOPL rules or a lawful federal order (§ 58-37-105(6)). Manufacturers and wholesalers may provide them only on an order from an appropriately licensed person, with records of the purchaser, drug, quantity, and dates (§ 58-17b-617(2)(b)).

Samples and patient assistance. Non-controlled drugs may be distributed as samples to persons licensed to sell, prescribe, administer, or research legend drugs, or supplied through a manufacturer's patient assistance program to qualifying patients (§ 58-17b-617(2)(a)). Buying or selling samples remains unlawful (§ 58-17b-501(4)), and federal PDMA rules limit sample distribution to practitioners and to health care entity pharmacies at a practitioner's request.

Supply-chain documentation. Under the federal DSCSA, the pharmacy deals only with authorized trading partners and keeps transaction information and statements for six years . Utah's wholesale rule adds pedigree requirements for drugs that have left the normal distribution channel, kept five years (R156-17b-615(10)).

Stock labeling. Manufacturers and wholesalers may sell only stock containers labeled with the manufacturer's (and any packer's or distributor's) name and place of business, with tablets and capsules marked with an identification code, and each package bearing an expiration date and lot number (§ 58-17b-616).

Sales outside the normal course of business (§ 58-17b-615)

Prescription drugs sold in bankruptcy, at public auction, at freight liquidation , or in any other sale outside the normal course of business are subject to special rules:

The seller must be licensed as a prescription drug distributor or wholesaler, with a regular license or a temporary license for that sale , and must retain a Utah-licensed pharmacist to verify proper transport, storage, and condition. The seller gives DOPL written notice before the sale.

A pharmacy may acquire such drugs only if they come with a certificate signed by the seller's pharmacist that they were not adversely affected, and a qualified pharmacist employed by the buyer determines they pose no greater threat than drugs bought through normal channels.

The verifying pharmacist (and any pharmacy or wholesaler employing or connected to that pharmacist) may not buy from that seller.

Sales to practitioners for office use (§ 58-17b-624; R156-17b-624)

A licensed pharmacy may repackage or compound a prescription drug for sale to a practitioner if:

  • the drug is not a compounded drug, or it is compounded but not a controlled substance ;
  • the pharmacy labels it "for office use only" ;
  • the practitioner administers it in the office or facility; and

the practitioner does not dispense it to the patient (except a DMP under Part 8).

R156-17b-624 requires compliance with all state and federal law, including the FDCA . Under federal law, compounding without patient-specific prescriptions can take a pharmacy outside the section 503A exemptions (Section 12.1).

Pharmacy-to-pharmacy and intracompany distribution

A chain pharmacy warehouse performs intracompany sales or transfers to chain pharmacies under common ownership (R156-17b-102(8)). It is licensed in the appropriate class.

Transfers of controlled substances between separately registered locations, even under the same owner, require DEA records (Form 222 or CSOS for Schedule II, invoices for Schedules III–V) and fall under the 5% rule unless the pharmacy is registered as a distributor (21 CFR 1307.11).

  • Delivering dispensed prescriptions to patients
  • The statute (§ 58-17b-602(9))

A pharmacy may deliver a prescription drug to a patient or the patient's agent only:

in person at the pharmacy ; or

by the U.S. Postal Service , a licensed common carrier , or supportive personnel , if the pharmacy takes reasonable precautions to make sure the drug is delivered to the patient or agent, or returned to the pharmacy .

The rule (R156-17b-608(1))

A pharmacy that delivers by USPS, common carrier, or supportive personnel must:

use shipping containers and processes that keep the drug stable, potent, and at appropriate temperatures throughout delivery, using packaging the manufacturer or USP <1079> recommends;

seal containers so opening or tampering is evident ;

have policies and procedures for accountability, safe delivery, temperature compliance, late arrivals, and replacing compromised drugs;

provide an electronic, telephone, or written way to offer counseling ; and

tell the patient what to do if the package or drug was compromised in shipment.

Supportive personnel may deliver a pre-filled prescription without a pharmacist in the immediate area (R156-17b-607). Counseling for delivered prescriptions is covered in Section 5.1. Undeliverable returns may be redistributed only if they come back within 14 days and meet the other conditions in R156-17b-608(2) (Section 7.3). A Class D pharmacy delivering into Utah must provide a toll-free counseling number and notify patients of substitutions.

Controlled substances

Registrants may ship dispensed controlled substances to patients by mail or common carrier in compliance with federal and carrier rules. Filling or advertising the filling of prescriptions for Utah residents without a Utah license or a license in the dispensing state is unlawful and a third degree felony (§§ 58-17b-501(7), -504(1)).

Scenario

A liquidation company offers a pharmacy pallets of prescription drugs from a bankrupt distributor at deep discounts. The pharmacy may buy only if the seller is licensed (at least temporarily), a seller-retained Utah pharmacist certifies that the drugs were not adversely affected, and the pharmacy's own pharmacist determines they pose no added risk. Otherwise, it must decline.